Trials / Completed
CompletedNCT03609606
A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects
An Open-label, Randomized, Multiple-dose Crossover Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A study to investigate drug interaction between D326, D337, and D013 in healthy male subjects
Detailed description
An open-label, randomized, multiple-dose crossover study to investigate drug interaction between D326, D337, and D013 in healthy male subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | D013, D326 and D337 | Daily oral administration of 1 tablet for each drug under fasting conditions for 7 days |
| DRUG | D013 | Daily oral administration of 1 tablet under fasting conditions for 7 days |
| DRUG | D326 and D337 | Daily oral administration of 1 tablet for each drug under fasting conditions for 7 days |
Timeline
- Start date
- 2018-08-09
- Primary completion
- 2018-09-14
- Completion
- 2018-09-27
- First posted
- 2018-08-01
- Last updated
- 2018-10-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03609606. Inclusion in this directory is not an endorsement.